Correlation of Exhaled Breath Temperature with Bronchial Blood Flow in Asthma

Overview

Journal Respir Res

Specialty Pulmonary Medicine

Date 2005 Feb 12

PMID 15705206

Citations 12

Authors

Paolo Paredi

Sergei A Kharitonov

Peter J Barnes

Affiliations

Soon will be listed here.

Abstract

In asthma elevated rates of exhaled breath temperature changes (Deltae degrees T) and bronchial blood flow (Qaw) may be due to increased vascularity of the airway mucosa as a result of inflammation.We investigated the relationship of Deltae degrees T with Qaw and airway inflammation as assessed by exhaled nitric oxide (NO). We also studied the anti-inflammatory and vasoactive effects of inhaled corticosteroid and beta2-agonist.Deltae degrees T was confirmed to be elevated (7.27 +/- 0.6 Delta degrees C/s) in 19 asthmatic subjects (mean age +/- SEM, 40 +/- 6 yr; 6 male, FEV1 74 +/- 6 % predicted) compared to 16 normal volunteers (4.23 +/- 0.41 Delta degrees C/s, p < 0.01) (30 +/- 2 yr) and was significantly increased after salbutamol inhalation in normal subjects (7.8 +/- 0.6 Delta degrees C/ s, p < 0.05) but not in asthmatic patients. Qaw, measured using an acetylene dilution method was also elevated in patients with asthma compared to normal subjects (49.47 +/- 2.06 and 31.56 +/- 1.6 mul/ml/min p < 0.01) and correlated with exhaled NO (r = 0.57, p < 0.05) and Deltae degrees T (r = 0.525, p < 0.05). In asthma patients, Qaw was reduced 30 minutes after the inhalation of budesonide 400 mug (21.0 +/- 2.3 mul/ml/min, p < 0.05) but was not affected by salbutamol.Deltae degrees T correlates with Qaw and exhaled NO in asthmatic patients and therefore may reflect airway inflammation, as confirmed by the rapid response to steroids.

Citing Articles

Exhaled Breath Analysis: From Laboratory Test to Wearable Sensing.

Heng W, Yin S, Chen Y, Gao W IEEE Rev Biomed Eng. 2024; 18:50-73.

PMID: 39412981 PMC: 11875904. DOI: 10.1109/RBME.2024.3481360.

High-Temporal-Resolution Kinetic Modeling of Lung Tumors with Dual-Blood Input Function Using Total-Body Dynamic PET.

Wang Y, Abdelhafez Y, Spencer B, Verma R, Parikh M, Stollenwerk N J Nucl Med. 2024; 65(5):714-721.

PMID: 38548347 PMC: 11064825. DOI: 10.2967/jnumed.123.267036.

Measurement of exhaled breath temperature in patients under general anesthesia: A feasibility study.

Guo L, Shi J, Liu D, Wang Y, Tong H, Feng Y Biomed Rep. 2023; 18(3):18.

PMID: 36776785 PMC: 9912139. DOI: 10.3892/br.2023.1600.

A Low-Cost Flexible Perforated Respiratory Sensor Based on Platinum for Continuous Respiratory Monitoring.

Cao L, Zhang Z, Li J, Wang Z, Ren Y, Wang Q Micromachines (Basel). 2022; 13(10).

PMID: 36296096 PMC: 9611104. DOI: 10.3390/mi13101743.

Fractional exhaled breath temperature in patients with asthma, chronic obstructive pulmonary disease, or systemic sclerosis compared to healthy controls.

Tufvesson E, Nilsson E, Popov T, Hesselstrand R, Bjermer L Eur Clin Respir J. 2020; 7(1):1747014.

PMID: 32363017 PMC: 7178872. DOI: 10.1080/20018525.2020.1747014.

References

Salvato G . Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax. 2001; 56(12):902-6. PMC: 1745985. DOI: 10.1136/thorax.56.12.902. View

McDonald D . Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med. 2001; 164(10 Pt 2):S39-45. DOI: 10.1164/ajrccm.164.supplement_2.2106065. View

Paredi P, Kharitonov S, Barnes P . Faster rise of exhaled breath temperature in asthma: a novel marker of airway inflammation?. Am J Respir Crit Care Med. 2002; 165(2):181-4. DOI: 10.1164/ajrccm.165.2.2103053. View

Vignola A, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V . Airway remodeling in asthma. Chest. 2003; 123(3 Suppl):417S-22S. DOI: 10.1378/chest.123.3_suppl.417s. View

Paredi P, Caramori G, Cramer D, Ward S, Ciaccia A, Papi A . Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease. Eur Respir J. 2003; 21(3):439-43. DOI: 10.1183/09031936.03.00061902. View

Mendes E, Pereira A, Danta I, Duncan R, Wanner A . Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids. Eur Respir J. 2003; 21(6):989-93. DOI: 10.1183/09031936.03.00072402. View

Jibelian G, Mitchell R, Overland E . Influence of hematocrit and temperature on solubility of acetylene and dimethyl ether. J Appl Physiol Respir Environ Exerc Physiol. 1981; 51(5):1357-61. DOI: 10.1152/jappl.1981.51.5.1357. View

Bland J, Altman D . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1(8476):307-10. View

. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis. 1987; 136(1):225-44. DOI: 10.1164/ajrccm/136.1.225. View

10.

Laitinen L, Laitinen M, Widdicombe J . Dose-related effects of pharmacological mediators on tracheal vascular resistance in dogs. Br J Pharmacol. 1987; 92(4):703-9. PMC: 1853723. DOI: 10.1111/j.1476-5381.1987.tb11374.x. View

11.

Chediak A, Elsasser S, Csete M, Gazeroglu H, Wanner A . Effect of histamine on tracheal mucosal perfusion, water content and airway smooth muscle in sheep. Respir Physiol. 1991; 84(2):231-43. DOI: 10.1016/0034-5687(91)90120-8. View

12.

Parsons G, Nichol G, Barnes P, Chung K . Peptide mediator effects on bronchial blood velocity and lung resistance in conscious sheep. J Appl Physiol (1985). 1992; 72(3):1118-22. DOI: 10.1152/jappl.1992.72.3.1118. View

13.

Kharitonov S, Yates D, Robbins R, Shinebourne E, Barnes P . Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994; 343(8890):133-5. DOI: 10.1016/s0140-6736(94)90931-8. View

14.

Robbins R, Springall D, Warren J, Kwon O, Buttery L, Wilson A . Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem Biophys Res Commun. 1994; 198(3):835-43. DOI: 10.1006/bbrc.1994.1119. View

15.

Onorato D, Demirozu M, Breitenbucher A, Atkins N, Chediak A, Wanner A . Airway mucosal blood flow in humans. Response to adrenergic agonists. Am J Respir Crit Care Med. 1994; 149(5):1132-7. DOI: 10.1164/ajrccm.149.5.8173752. View

16.

Cremona G, Wood A, Hall L, Bower E, Higenbottam T . Effect of inhibitors of nitric oxide release and action on vascular tone in isolated lungs of pig, sheep, dog and man. J Physiol. 1994; 481 ( Pt 1):185-95. PMC: 1155876. DOI: 10.1113/jphysiol.1994.sp020429. View

17.

Scuri M, McCaskill V, Chediak A, Abraham W, Wanner A . Measurement of airway mucosal blood flow with dimethylether: validation with microspheres. J Appl Physiol (1985). 1995; 79(4):1386-90. DOI: 10.1152/jappl.1995.79.4.1386. View

18.

Degnim A, Nakayama D . Nitric oxide and the pulmonary artery smooth muscle cell. Semin Pediatr Surg. 1996; 5(3):160-4. View

19.

Charan N, Johnson S, Lakshminarayan S, Thompson W, Carvalho P . Nitric oxide and beta-adrenergic agonist-induced bronchial arterial vasodilation. J Appl Physiol (1985). 1997; 82(2):686-92. DOI: 10.1152/jappl.1997.82.2.686. View

20.

Kharitonov S, Alving K, Barnes P . Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J. 1997; 10(7):1683-93. DOI: 10.1183/09031936.97.10071683. View